ATE480566T1 - Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs - Google Patents
Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebsInfo
- Publication number
- ATE480566T1 ATE480566T1 AT99925216T AT99925216T ATE480566T1 AT E480566 T1 ATE480566 T1 AT E480566T1 AT 99925216 T AT99925216 T AT 99925216T AT 99925216 T AT99925216 T AT 99925216T AT E480566 T1 ATE480566 T1 AT E480566T1
- Authority
- AT
- Austria
- Prior art keywords
- prostate cancer
- treating prostate
- immunotherapeutic composition
- immunotherapeutic
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8928198P | 1998-06-15 | 1998-06-15 | |
| PCT/IB1999/001115 WO1999065523A1 (en) | 1998-06-15 | 1999-06-15 | Immunotherapeutic composition and method for the treatment of prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE480566T1 true ATE480566T1 (de) | 2010-09-15 |
Family
ID=22216751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99925216T ATE480566T1 (de) | 1998-06-15 | 1999-06-15 | Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6881405B2 (de) |
| EP (1) | EP1085905B1 (de) |
| JP (1) | JP2002518347A (de) |
| AT (1) | ATE480566T1 (de) |
| AU (1) | AU768002B2 (de) |
| CA (1) | CA2328504A1 (de) |
| DE (1) | DE69942742D1 (de) |
| IL (1) | IL139700A (de) |
| WO (1) | WO1999065523A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8038994B2 (en) | 1996-05-15 | 2011-10-18 | Quest Pharmatech Inc. | Combination therapy for treating disease |
| ATE480566T1 (de) * | 1998-06-15 | 2010-09-15 | Quest Pharmatech Inc | Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs |
| MXPA01007148A (es) | 1999-01-13 | 2002-03-27 | Igeneon Krebs Immuntherapie | Uso de anticuerpos para vacunacion anti-cancer. |
| CA2408547A1 (en) * | 2000-05-11 | 2001-11-15 | Altarex Corp. | Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| HRP20041037A2 (en) * | 2002-04-11 | 2005-06-30 | Altarex Medical Corporation | Binding agents and their use in targeting tumor cells |
| EP1578445A4 (de) * | 2002-10-17 | 2007-04-04 | Altarex Medical Corp | Therapeutisches adjuvans |
| US7902338B2 (en) | 2003-07-31 | 2011-03-08 | Immunomedics, Inc. | Anti-CD19 antibodies |
| GB0329146D0 (en) * | 2003-12-16 | 2004-01-21 | Glaxosmithkline Biolog Sa | Vaccine |
| CA2523032A1 (en) | 2005-10-07 | 2007-04-07 | Immunovaccine Technologies Inc. | Vaccines for cancer therapy |
| US20080095790A1 (en) * | 2006-10-24 | 2008-04-24 | Perambakam Supriya M | Methods of Treating Prostate Cancer |
| ES2588705T3 (es) * | 2007-09-27 | 2016-11-04 | Immunovaccine Technologies Inc. | Uso de liposomas en un vehículo que comprende una fase hidrófoba continua para la entrega de polinucleótidos in vivo |
| US20100209452A1 (en) * | 2007-10-03 | 2010-08-19 | Immunovaccine Technologies, Inc | Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
| EP2331130B1 (de) * | 2008-04-09 | 2018-02-14 | Oncoquest Inc. | Ige-antikörper zur behandlung von krebs |
| CA2723918C (en) | 2008-06-05 | 2018-01-09 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| GB0811567D0 (en) * | 2008-06-24 | 2008-07-30 | Cytosystems Ltd | Assay |
| PL3912643T3 (pl) | 2009-02-13 | 2023-01-23 | Immunomedics Inc. | Immunokoniugaty z połączeniem rozszczepialnym wewnątrzkomórkowo |
| WO2011034660A1 (en) | 2009-09-16 | 2011-03-24 | Immunomedics, Inc. | Class i anti-cea antibodies and uses thereof |
| IN2012DN03354A (de) | 2009-12-02 | 2015-10-23 | Immunomedics Inc | |
| US9023802B2 (en) * | 2009-12-14 | 2015-05-05 | Immatics Biotechnologies Gmbh | HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |
| AU2012250924B2 (en) | 2011-05-02 | 2017-05-25 | Immunomedics, Inc. | Ultrafiltration concentration of allotype selected antibodies for small-volume administration |
| IN2014CN02581A (de) | 2011-10-06 | 2015-08-07 | Immunovaccine Technologies Inc | |
| AU2013302696B9 (en) | 2012-08-14 | 2018-08-09 | Ibc Pharmaceuticals, Inc. | T-cell redirecting bispecific antibodies for treatment of disease |
| CN107753954A (zh) | 2012-12-13 | 2018-03-06 | 免疫医疗公司 | 功效改进且毒性降低的抗体与sn‑38的免疫缀合物的剂量 |
| ES2978993T3 (es) | 2014-02-21 | 2024-09-23 | Ibc Pharmaceuticals Inc | Terapia de enfermedades mediante la inducción de la respuesta inmunitaria a las células que expresan Trop-2 |
| CA2935748A1 (en) | 2014-02-25 | 2015-09-03 | Immunomedics, Inc. | Humanized rfb4 anti-cd22 antibody |
| US9580495B2 (en) | 2014-06-24 | 2017-02-28 | Immunomedics, Inc. | Anti-histone therapy for vascular necrosis in severe glomerulonephritis |
| PL3204018T3 (pl) | 2014-10-07 | 2022-01-03 | Immunomedics, Inc. | Neoadiuwantowe zastosowanie koniugatów przeciwciało-lek |
| EP3286224A4 (de) | 2015-04-22 | 2018-11-14 | Immunomedics, Inc. | Isolierung, detektion, diagnose und/oder charakterisierung von zirkulierenden trop-2-positiven krebszellen |
| PT3313443T (pt) | 2015-06-25 | 2023-08-30 | Immunomedics Inc | Combinação de anticorpos anti-hla-dr ou anti-trop-2 com inibidores de microtúbulos, inibidores de parp, inibidores de bruton quinase ou inibidores de fosfoinositídeo 3-quinase melhora significativamente o resultado terapêutico no cancro |
| PL3316885T3 (pl) | 2015-07-01 | 2021-12-06 | Immunomedics, Inc. | Immunokoniugaty przeciwciało-sn-38 z linkerem cl2a |
| EP4342497A1 (de) | 2021-05-10 | 2024-03-27 | Kawasaki Institute of Industrial Promotion | Antikörper mit reduzierter bindungsaffinität für antigen |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3865689A (en) | 1972-11-09 | 1975-02-11 | Hoffmann La Roche | Method of producing carcinoembryonic antigens |
| US4446122A (en) | 1979-12-28 | 1984-05-01 | Research Corporation | Purified human prostate antigen |
| US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
| US5053224A (en) | 1983-11-07 | 1991-10-01 | Hilary Koprowski | Induction of antibody response to solid tumors with anti-idiotype antibodies |
| DE3650139T2 (de) | 1985-07-05 | 1995-03-09 | Hutchinson Fred Cancer Res | Verfahren zum reduzieren der immunogenizität und zum induzieren immunologischer toleranz. |
| EP0234122A3 (de) | 1986-02-21 | 1989-03-22 | Oncogen Limited Partnership | Tumortherapie mit biologisch aktiven Anti-Tumor-Antikörpern |
| AU613590B2 (en) | 1986-11-19 | 1991-08-08 | Bristol-Myers Squibb Company | Hybridomas producing monoclonal antibodies to new mucin epitopes |
| US5059680A (en) | 1986-11-24 | 1991-10-22 | Centocor, Inc. | Method of isolating ca 125 antigen |
| US5683674A (en) | 1987-01-07 | 1997-11-04 | Imperial Cancer Research Technology Ltd. | Antibody against human mucin core protein and method of preparing and using same |
| US4859449A (en) | 1987-09-14 | 1989-08-22 | Center For Molecular Medicine And Immunology | Modified antibodies for enhanced hepatocyte clearance |
| GB8728856D0 (en) | 1987-12-10 | 1988-01-27 | Bradwell A R | Tumour-locating agents & method of locating tumours |
| CA2065874C (en) | 1989-09-15 | 2001-12-11 | Joseph P. Brown | Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| US5165922A (en) | 1990-05-22 | 1992-11-24 | Bristol-Myers Squibb Company | Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
| DE4133791A1 (de) | 1991-10-11 | 1993-04-15 | Behringwerke Ag | Monoklonale antikoerper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung und ihre verwendung |
| EP0652014A1 (de) * | 1993-11-10 | 1995-05-10 | National Institute Of Immunology | Behandlung von Prostatahypertrophie |
| US5773292A (en) | 1995-06-05 | 1998-06-30 | Cornell University | Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood |
| US6143509A (en) | 1996-02-06 | 2000-11-07 | Abbott Laboratories | Prostate specific antigen peptides and uses thereof |
| GB9606228D0 (en) | 1996-03-25 | 1996-05-29 | Secr Defence | Apparatus for matrix coating fibres with metal vapour |
| AU4086397A (en) | 1996-09-06 | 1998-03-26 | Centocor Inc. | Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen |
| ATE480566T1 (de) * | 1998-06-15 | 2010-09-15 | Quest Pharmatech Inc | Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs |
-
1999
- 1999-06-15 AT AT99925216T patent/ATE480566T1/de not_active IP Right Cessation
- 1999-06-15 AU AU41594/99A patent/AU768002B2/en not_active Ceased
- 1999-06-15 CA CA002328504A patent/CA2328504A1/en not_active Abandoned
- 1999-06-15 US US09/332,866 patent/US6881405B2/en not_active Expired - Lifetime
- 1999-06-15 EP EP99925216A patent/EP1085905B1/de not_active Expired - Lifetime
- 1999-06-15 DE DE69942742T patent/DE69942742D1/de not_active Expired - Lifetime
- 1999-06-15 JP JP2000554401A patent/JP2002518347A/ja active Pending
- 1999-06-15 WO PCT/IB1999/001115 patent/WO1999065523A1/en not_active Ceased
- 1999-06-15 IL IL13970099A patent/IL139700A/xx not_active IP Right Cessation
-
2004
- 2004-10-14 US US10/966,789 patent/US7579445B2/en not_active Expired - Fee Related
-
2007
- 2007-10-31 US US11/981,715 patent/US20090220493A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1085905A1 (de) | 2001-03-28 |
| US6881405B2 (en) | 2005-04-19 |
| AU4159499A (en) | 2000-01-05 |
| US20050202018A1 (en) | 2005-09-15 |
| US7579445B2 (en) | 2009-08-25 |
| WO1999065523A1 (en) | 1999-12-23 |
| CA2328504A1 (en) | 1999-12-23 |
| DE69942742D1 (de) | 2010-10-21 |
| JP2002518347A (ja) | 2002-06-25 |
| IL139700A0 (en) | 2002-02-10 |
| IL139700A (en) | 2005-09-25 |
| AU768002B2 (en) | 2003-11-27 |
| US20020136715A1 (en) | 2002-09-26 |
| EP1085905B1 (de) | 2010-09-08 |
| US20090220493A1 (en) | 2009-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69942742D1 (de) | Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs | |
| CY1109525T1 (el) | ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΑ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ErbB2 ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ErbB2 | |
| ATE208210T1 (de) | Kombination von proteintyrosin-kinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs | |
| DE69830072D1 (de) | Radioaktive zusammensetzungen zur behandlung von prostatatumoren | |
| UA111707C2 (uk) | Застосування виділеного анти-tnf-альфа антитіла людини | |
| CY1120070T1 (el) | Μεθοδοi θεραπευτικης αγωγης με τη χρηση συζευγματων αντισωματος εναντι-erbb-μεϋτανσινοειδους | |
| DE60027732D1 (de) | Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems | |
| ATE330631T1 (de) | Antikörperfragmente zur lokalen behandlung von augenerkrankungen | |
| DE69931377D1 (de) | Verfahren zur behandlung von ig-e assozierten krankheiten und zusammensetzungen zur verwendung in diesen verfahren | |
| ATE453405T1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs | |
| BR9707819A (pt) | Imunogenos peptidicos | |
| NO20070052L (no) | Fremgangsmate for behandling av multippel sklerose | |
| EP1117842A4 (de) | Verfahren zur selektion von behandlungsmethoden für prostatakrebs sowie behandlung von prostatakrebs | |
| ATE520466T1 (de) | Apparat und verfahren zur modifizierung von magnetisch inmmobilizierte biomolekulen | |
| FR12C0004I1 (de) | ||
| DK1187632T3 (da) | Behandling med anti-ErbB2-antistoffer | |
| ATE411018T1 (de) | Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en) | |
| DE69921130D1 (de) | Verfahren und stoffe zur behandlung des prostatakarzinomes | |
| ATE495751T1 (de) | Behandlung von bauchspeicheldrüsenkrebs mit einem monoklonalen antikörper | |
| DE69125485D1 (de) | Verfahren und zwischenprodukte synthetischer antikörperderivate | |
| DE69426767D1 (de) | Anti idiotypische Antikörper gegen Gonococcen und diese verwendende Verfahren und Zusammensetzungen. | |
| ATE283920T1 (de) | Verfahren zur immunisierung und behandlung von h. pylori infektion | |
| ATE290881T1 (de) | Verwendung von anti-ferritin antikörper bei der behandlung von bestimmten krebsarten | |
| DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
| ATE335504T1 (de) | Humanisierte antikörper zur erkennung von verotoxin ii sowie zellinie zur herstellung derselben |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |